However, we have recently shown that PI 3-K protein kinase activity is deregulated in >80% of primary AML patient samples [23], [38] and that PI 3-K-mediated phosphorylation of the GM-CSF/IL-3 receptors regulates cell survival [23]. This evidence concerns the gene CSF2 and acute myeloid leukemia.